What is the current stock price of Hyperfine, Inc. (HYPR)?

As of the latest market data, Hyperfine, Inc. (HYPR) is trading at $1.21. The stock has seen a loss of 0.00% today.

Does Hyperfine, Inc. (HYPR) pay a dividend?

Based on current data, Hyperfine, Inc. does not have a confirmed active dividend policy.

What is the market cap of Hyperfine, Inc.?

The current market capitalization of Hyperfine, Inc. (HYPR) is approximately unavailable.

HYPR

Hyperfine, Inc.·Healthcare

1.21

0.000%(+0.00)

Market Closed

1.26

4.132%(+0.05)

After Hours

Last Updated: — ET

52W L: $0.5352W H: $2.22

HYPR NEWS

businesswire.com

1d ago

Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software

GUILFORD, Conn.--(BUSINESS WIRE)--Next-gen Swoop system and latest Optive AI software receive CE & UKCA marks, bringing Hyperfine's most advanced portable MRI tech to European markets.

prnewswire.com

Mar 27

How Decentralized AI is Unlocking Value in Cardiac Diagnostics

/PRNewswire/ -- USANewsGroup.com News Commentary - Heart disease is a quiet crisis that is draining healthcare resources worldwide, currently costing the

businesswire.com

Mar 23

Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine

FARMINGTON, Conn.--(BUSINESS WIRE)--Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, today announced it has provided a $40 million loan facility to Hyperfine, Inc. (NASDAQ: HYPR) (“Hyperfine”), with an initial funding of $15 million at closing, and up to $25 million available to support future commercial growth. Hyperfine is a publicly traded health technology company that has developed and is commercializing the Swoop® System, t.

defenseworld.net

Mar 22

Hyperfine (NASDAQ:HYPR) and Atossa Genetics (NASDAQ:ATOS) Critical Comparison

Hyperfine (NASDAQ: HYPR - Get Free Report) and Atossa Genetics (NASDAQ: ATOS - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk. Analyst Recommendations This is a summary of current

seekingalpha.com

Mar 18

Hyperfine, Inc. (HYPR) Q4 2025 Earnings Call Transcript

businesswire.com

Mar 18

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2025 financial results and provided a business update. “The launch of our second-generation Swoop® scanner, our Optive AI™ software, and the addition of a new market in the neurology office setting in.

Company Profile

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Sector

Healthcare

Industry

Medical - Devices

Employees

111

IPO Date

2021-01-28

Beta

1.06

Websitehyperfine.io↗